EPHX2 and cardiovascular disorder: Selaginellin derivatives 1–3 isolated from Selaginellatamariscina were evaluated for their inhibition of soluble epoxide hydrolase (sEH) to demonstrate their potential for the treatment of cardiovascular disease.